Tag: multiple sclerosis (ms)

Updated European guidelines on the treatment of patients with multiple sclerosis (MS) have been announced, and include a recommendation for siponimod (Mayzent) in progressive MS, as well as a general emphasis toward earlier and more aggressive treatment. The updated guidelines were presented at last week’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

“Symptoms, then, are in reality nothing but a cry from suffering organs” – Jean-Martin Charcot Nearly 130 years after his death, Jean-Martin Charcot’s name still resonates with modern neurologists. The famed 19th century French physician made myriad enduring contributions to the field. His eponymous foot condition might be his best known. He also delved into